MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$11,583K
Prepaid expenses and
other current assets
$1,420K
Accounts receivable, net
of allowance for...
$1,128K
Restricted cash, current
$729K
Inventories
$446K
Total current assets
$15,306K
Machinery and equipment,
net, and...
$6,435K
Right-of-use operating and
financing lease assets,...
$2,815K
Restricted cash,
noncurrent
$607K
Other noncurrent
assets
$593K
Total assets
$25,756K
Accumulated deficit
-$400,761K
Total liabilities and
shareholders' deficit
$25,756K
Total shareholders'
deficit
-$31,464K
Common stock, no par
value, 230,000 shares...
$369,211K
Accumulated other
comprehensive income
$86K
Total liabilities
$57,220K
Contingent consideration
liabilities, noncurrent
$43,455K
Total current
liabilities
$12,075K
Operating and financing
lease liabilities,...
$1,690K
Due to related party
(note 9)
$2,780K
Accounts payable
$2,544K
Accrued compensation
$2,461K
Operating and financing
lease liabilities,...
$1,807K
Accrued royalties
$1,116K
Accrued expenses and
other current...
$939K
Contingent consideration
liabilities, current
$428K
Back
Back
Balance Sheet
source: myfinsight.com
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX)